Saturday, October 14, 2017 5:05:11 PM
In what I am seeing, I think sales are being held up because, if VDRM shows a good income stream and good financial results from sales, Keough will demand money in the court settlement.
If there is only a possibility of future fortune but no money to show at time of settlement, then Keough will settle for shares, which VDRM can grant without having to come up with capital by a certain date.
In short, based on the fact Biogenx is holding up shipments (ie, holding back sales/revenue), and all of the other news that we know from sources outside of VDRM, I think they are holding back to sway the type of restitution Keough will have to settle for.
There has to be something of value for Keough to be spending money in court, and for the court to not be dismissing the case, and VDRM and company have all the reasons in the world to push for a settlement that does not include a cash payout by a certain date. I'd say we are in a waiting game of when the case will be settled and what the settlement will be. Keough will not want to spend money indefinitely.... he will offer a settlement for shares.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM